個別化医療におけるナノ材料の世界市場規模調査＆予測、製品タイプ別、地域別分析、2023年～2030年

個別化医療におけるナノ材料の世界市場は、2022年に約3,115億米ドルと評価され、予測期間2023年～2030年には11.3%以上の成長率で成長すると予測されています。

個別化医療におけるナノ材料とは、個別化ヘルスケア分野での応用向けに設計・デザインされたナノスケールの材料を指します。個別化医療は、遺伝、環境、ライフスタイルなどの要因を考慮し、患者一人ひとりの特性に合わせた医療を目指すものです。ナノ材料は、独自の特性や機能を提供することで、この文脈において重要な役割を果たしています。個別化医療市場におけるナノ材料の使用は、がんの有病率の増加や糖尿病患者の増加などの要因によって拡大しています。ナノ材料は、診断と治療の機能性を併せ持つ体内診断プラットフォームに採用されています。これらのプラットフォームはイメージングと治療を同時に可能にし、ヘルスケアプロバイダーが治療反応をモニターし、個々の患者のニーズに基づいて治療を調整することを可能にします。その結果、個別化医療におけるナノ材料の需要は、予測期間2023年～2030年の間に国際市場で徐々に増加しています。

ナノ材料は、抗がん剤を腫瘍部位に直接送達するように設計することができ、標的での薬物濃度を高め、健康な組織へのダメージを最小限に抑えることができます。がんの不均一性は個別化アプローチを必要とし、ナノキャリアは特定のがんタイプ、あるいは個々の患者プロファイルに合わせることができます。Global Cancer Observatoryによると、世界中の脳・神経系がんの患者数は2020年に30万8,000人、2030年には37万2,000人に達すると予測されています。さらに、世界保健機関（WHO）によると、2020年には、世界で約1,930万件の新規がん症例が記録されたと推定されており、この症例数は増加し、2040年には3,020万件に達すると予測されています。個別化医療におけるナノ材料市場を牽引するもう一つの重要な要因は、糖尿病患者の増加です。ナノ材料ベースのバイオセンサーは、糖尿病患者の血糖値をより高感度で正確にモニタリングするために採用することができます。これらのバイオセンサーはリアルタイムのデータを提供することができるため、糖尿病の管理を改善し、個々のグルコースの変動に基づいて治療計画をカスタマイズすることができます。また、米国糖尿病協会によると、2021年には、全人口の11.6%に当たる3,840万人の米国人が糖尿病に罹患しています。さらに、高コレステロール血症の症例の増加と個別化医療におけるナノ材料に関連する技術の進歩は、予測期間中、市場に有利な成長機会をもたらすと予想されます。しかし、個別化医療の高い市場開拓コストと個別化医療の処方に関する政府の規制は、2023年～2030年の予測期間を通じて市場全体の成長を阻害することになるでしょう。

個別化医療におけるナノ材料の世界市場調査において考慮した主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカが含まれます。北米は、同地域における個別化医療の研究開発の進展に起因して、2022年に最大の市場シェアで市場を独占しました。個別化医療の進歩は、病気に関連する特定のバイオマーカーの同定に貢献しています。ナノ材料は、これらのバイオマーカーを検出し標的とするように設計することができ、早期診断と個別化治療戦略を可能にします。この地域の圧倒的な実績は、個別化医療におけるナノ材料の需要全体を促進すると予想されます。さらに、アジア太平洋地域は、同地域におけるヘルスケア支出の増加などの要因により、予測期間中に最も急成長する地域となる見込みです。資金の増加により、ヘルスケア機関はナノ材料をベースとした技術の開発と導入に必要な最先端のインフラと設備に投資することができます。高度な研究所、画像処理施設、製造能力は、ナノ材料の製造と検査に不可欠であり、個別化医療アプリケーションの成長に寄与しています。

この調査の目的は、近年のさまざまなセグメントと国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

• 製品タイプ
• タンパク質
• モノクローナル抗体
• ナノ結晶
• リポソーム
• 金ナノ粒子
• 量子ドット

目次

第1章 エグゼクティブサマリー

第2章 個別化医療におけるナノ材料の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 個別化医療におけるナノ材料の世界市場力学

• 個別化医療におけるナノ材料市場の影響分析（2020年～2030年）
  • 市場促進要因
    • 慢性がん疾患の有病率の増加
    • 糖尿病患者の増加
  • 市場の課題
    • 個別化医療の開発コストの高さ
    • 個別化医療の処方に関する政府の規制
  • 市場機会
    • 高コレステロール血症の増加
    • 個別化医療におけるナノ材料に関連する技術の進歩

第4章 個別化医療におけるナノ材料の世界市場産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治的
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 個別化医療におけるナノ材料の世界市場：製品タイプ別

• 市場スナップショット
• 個別化医療におけるナノ材料の世界市場：製品タイプ別、実績 - ポテンシャル分析
• 個別化医療におけるナノ材料の世界市場：製品タイプ別推定・予測、2020年～2030年
• 個別化医療におけるナノ材料市場、サブセグメント分析
  • タンパク質
  • モノクローナル抗体
  • ナノ結晶
  • リポソーム
  • 金ナノ粒子
  • 量子ドット

第6章 個別化医療におけるナノ材料の世界市場、地域分析

• 主要国
• 主な新興国
• 個別化医療におけるナノ材料市場、地域別市場スナップショット
• 北米
  • 米国
    • 製品タイプ別の推定・予測、2020年～2030年
  • カナダ
• 欧州の個別化医療におけるナノ材料市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• アジア太平洋の個別化医療におけるナノ材料市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカの個別化医療におけるナノ材料市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他の中東・アフリカ

第7章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Bristol-Myers Squibb Company
    • 主要情報
    • 概要
    • 財務（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • Eisai Co., Ltd
  • Gilead Sciences, Inc
  • Ipsen Pharma S.A
  • Abraxis BioScience, Inc
  • Camurus AB
  • Johnson & Johnson Services, Inc
  • Merck & Co., Inc
  • NanoCarrier Co., Ltd
  • Novartis AG

第8章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1.Global Nanomaterials in Personalized Medicine Market, report scope
• TABLE 2.Global Nanomaterials in Personalized Medicine Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3.Global Nanomaterials in Personalized Medicine Market estimates & forecasts by Product Type 2020-2030 (USD Billion)
• TABLE 4.Global Nanomaterials in Personalized Medicine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 5.Global Nanomaterials in Personalized Medicine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 6.Global Nanomaterials in Personalized Medicine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7.Global Nanomaterials in Personalized Medicine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8.Global Nanomaterials in Personalized Medicine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9.Global Nanomaterials in Personalized Medicine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10.Global Nanomaterials in Personalized Medicine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11.Global Nanomaterials in Personalized Medicine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12.Global Nanomaterials in Personalized Medicine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13.Global Nanomaterials in Personalized Medicine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14.U.S. Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15.U.S. Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 16.U.S. Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 17.Canada Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 18.Canada Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19.Canada Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 20.UK Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 21.UK Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22.UK Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 23.Germany Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 24.Germany Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25.Germany Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 26.France Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 27.France Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28.France Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 29.Italy Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 30.Italy Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31.Italy Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 32.Spain Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 33.Spain Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34.Spain Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 35.RoE Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 36.RoE Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37.RoE Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 38.China Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 39.China Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40.China Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 41.India Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 42.India Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43.India Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 44.Japan Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 45.Japan Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46.Japan Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 47.South Korea Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 48.South Korea Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49.South Korea Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 50.Australia Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 51.Australia Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52.Australia Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 53.RoAPAC Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 54.RoAPAC Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55.RoAPAC Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 56.Brazil Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 57.Brazil Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58.Brazil Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 59.Mexico Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 60.Mexico Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61.Mexico Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 62.RoLA Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 63.RoLA Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64.RoLA Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 65.Saudi Arabia Nanomaterials in Personalized Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 66.South Africa Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67.RoMEA Nanomaterials in Personalized Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 68.List of secondary sources, used in the study of global Nanomaterials in Personalized Medicine Market
• TABLE 69.List of primary sources, used in the study of global Nanomaterials in Personalized Medicine Market
• TABLE 70.Years considered for the study
• TABLE 71.Exchange rates considered

LIST OF FIGURES

• FIG 1.Global Nanomaterials in Personalized Medicine Market, research methodology
• FIG 2.Global Nanomaterials in Personalized Medicine Market, Market estimation techniques
• FIG 3.Global Market size estimates & forecast methods
• FIG 4.Global Nanomaterials in Personalized Medicine Market, key trends 2022
• FIG 5.Global Nanomaterials in Personalized Medicine Market, growth prospects 2023-2030
• FIG 6.Global Nanomaterials in Personalized Medicine Market, porters 5 force model
• FIG 7.Global Nanomaterials in Personalized Medicine Market, pest analysis
• FIG 8.Global Nanomaterials in Personalized Medicine Market, value chain analysis
• FIG 9.Global Nanomaterials in Personalized Medicine Market by segment, 2020 & 2030 (USD Billion)
• FIG 10.Global Nanomaterials in Personalized Medicine Market by segment, 2020 & 2030 (USD Billion)
• FIG 11.Global Nanomaterials in Personalized Medicine Market by segment, 2020 & 2030 (USD Billion)
• FIG 12.Global Nanomaterials in Personalized Medicine Market by segment, 2020 & 2030 (USD Billion)
• FIG 13.Global Nanomaterials in Personalized Medicine Market by segment, 2020 & 2030 (USD Billion)
• FIG 14.Global Nanomaterials in Personalized Medicine Market, regional snapshot 2020 & 2030
• FIG 15.North America Nanomaterials in Personalized Medicine Market 2020 & 2030 (USD Billion)
• FIG 16.Europe Nanomaterials in Personalized Medicine Market 2020 & 2030 (USD Billion)
• FIG 17.Asia pacific Nanomaterials in Personalized Medicine Market 2020 & 2030 (USD Billion)
• FIG 18.Latin America Nanomaterials in Personalized Medicine Market 2020 & 2030 (USD Billion)
• FIG 19.Middle East & Africa Nanomaterials in Personalized Medicine Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Nanomaterials in Personalized Medicine Market is valued approximately USD 311.50 billion in 2022 and is anticipated to grow with a growth rate of more than 11.3% over the forecast period 2023-2030. Nanomaterials in Personalized Medicine refer to materials at the nanoscale that are engineered and designed for applications in the field of personalized healthcare. Personalized medicine aims to tailor medical treatment to the individual characteristics of each patient, considering factors such as genetics, environment and lifestyle. Nanomaterials play a crucial role in this context by offering unique properties and capabilities. Use of Nanomaterials in Personalized Medicine market is expanding because of factors such as growing prevalence of cancer and increasing number of diabetes cases. Nanomaterials are employed in theragnostic platforms that combine diagnostic and therapeutic functionalities. These platforms enable simultaneous imaging and treatment, allowing healthcare providers to monitor treatment responses and adjust therapies based on individual patient needs. As a result, the demand of Nanomaterials in Personalized Medicine has progressively increased in the international market during the forecast period 2023-2030.

Nanomaterials can be engineered to deliver anticancer drugs directly to tumor sites, increasing drug concentration at the target and minimizing damage to healthy tissues. The heterogeneity of cancer requires personalized approaches, and nanocarriers can be tailored to specific cancer types or even individual patient profiles. According to Global Cancer Observatory, the number of Brain, nervous system cancer cases across the world accounts 308 thousand cases in 2020 and is projected to reach up to 372 thousand cases by the year 2030. Furthermore, as per World Health Organization, in 2020, it was estimated that nearly 19.3 million new cases of cancer were recorded globally, which is projected to rise and is likely to reach 30.2 million new cases by 2040. Another important factor driving the Nanomaterials in Personalized Medicine market is increasing number of diabetes cases. Nanomaterial-based biosensors can be employed for more sensitive and accurate monitoring of blood glucose levels in diabetic patients. These biosensors can offer real-time data, allowing for better management of diabetes and customization of treatment plans based on individual glucose variations. In addition, as per American Diabetes Association, in 2021, 38.4 million Americans, or 11.6% of the total population, had diabetes 2 million Americans with type 1 diabetes, including around 304,000 children and adolescents. Moreover, growing cases of hypercholesterolemia and technological advancements associated with nanomaterials in personalized medicine is anticipated to create a lucrative growth opportunity for the market over the forecast period. However, high development cost of personalized medicine and government regulations regarding formulation of personalized medicine is going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Nanomaterials in Personalized Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the growing research and development in personalized medicine in the region. Advances in personalized medicine contribute to the identification of specific biomarkers associated with diseases. Nanomaterials can be engineered to detect and target these biomarkers, enabling early diagnosis and personalized treatment strategies. The region's dominant performance is anticipated to propel the overall demand of Nanomaterials in Personalized Medicine. Furthermore, Asia Pacific is expected to grow as a fastest growing region during the forecast period, owing to factors such as growing healthcare spending in the region. Increased funding allows healthcare institutions to invest in state-of-the-art infrastructure and equipment needed for the development and implementation of nanomaterial-based technologies. Advanced laboratories, imaging facilities, and manufacturing capabilities are essential for the production and testing of nanomaterials, contributing to the growth of personalized medicine applications.

Major market player included in this report are:

• Bristol-Myers Squibb Company
• Eisai Co., Ltd
• Gilead Sciences, Inc
• Ipsen Pharma S.A
• Abraxis BioScience, Inc
• Camurus AB
• Johnson & Johnson Services, Inc
• Merck & Co., Inc
• NanoCarrier Co., Ltd
• Novartis AG

Recent Developments in the Market:

• In June 2022, Ligandal Inc., a pioneer in personalised genomic medicine, biomaterials, and artificial intelligence, and Nanotronics, a developer of advanced intelligent inspection systems and adaptive manufacturing hardware has announced a collaboration to commercialise, develop, and provide next-generation technologies for gene therapy, peptide materials, nanomaterials, and biological technology characterization. The firms are going to work to create next-generation nanomaterials and end-to-end capabilities for designing, characterising, synthesising, and supporting diverse therapeutic initiatives, including in rare disease-related applications, haematology, infectious disease, and biodefense.

Global Nanomaterials in Personalized Medicine Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product Type, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

• Product Type
• Proteins
• Monoclonal Antibodies
• Nanocrystals
• Liposomes
• Gold Nanoparticles
• Quantum Dots

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Nanomaterials in Personalized Medicine Market, by region, 2020-2030 (USD Billion)
  • 1.2.2.Nanomaterials in Personalized Medicine Market, by Product Type, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Nanomaterials in Personalized Medicine Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Nanomaterials in Personalized Medicine Market Dynamics

• 3.1.Nanomaterials in Personalized Medicine Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Growing prevalence of chronic cancer diseases
    • 3.1.1.2.Increasing number of diabetes cases
  • 3.1.2.Market Challenges
    • 3.1.2.1.High development cost of personalized medicine
    • 3.1.2.2.Government regulations regarding formulation of personalized medicine
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Growing cases of hypercholesterolemia
    • 3.1.3.2.Technological advancements associated with nanomaterials in personalized medicine

Chapter 4.Global Nanomaterials in Personalized Medicine Market: Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economic
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Nanomaterials in Personalized Medicine Market, by Product Type

• 5.1.Market Snapshot
• 5.2.Global Nanomaterials in Personalized Medicine Market by Product Type, Performance - Potential Analysis
• 5.3.Global Nanomaterials in Personalized Medicine Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
• 5.4.Nanomaterials in Personalized Medicine Market, Sub Segment Analysis
  • 5.4.1.Proteins
  • 5.4.2.Monoclonal Antibodies
  • 5.4.3.Nanocrystals
  • 5.4.4.Liposomes
  • 5.4.5.Gold Nanoparticles
  • 5.4.6.Quantum Dots

Chapter 6.Global Nanomaterials in Personalized Medicine Market, Regional Analysis

• 6.1.Top Leading Countries
• 6.2.Top Emerging Countries
• 6.3.Nanomaterials in Personalized Medicine Market, Regional Market Snapshot
• 6.4.North America Nanomaterials in Personalized Medicine Market
  • 6.4.1.U.S. Nanomaterials in Personalized Medicine Market
    • 6.4.1.1.Product Type breakdown estimates & forecasts, 2020-2030
  • 6.4.2.Canada Nanomaterials in Personalized Medicine Market
• 6.5.Europe Nanomaterials in Personalized Medicine Market Snapshot
  • 6.5.1.U.K. Nanomaterials in Personalized Medicine Market
  • 6.5.2.Germany Nanomaterials in Personalized Medicine Market
  • 6.5.3.France Nanomaterials in Personalized Medicine Market
  • 6.5.4.Spain Nanomaterials in Personalized Medicine Market
  • 6.5.5.Italy Nanomaterials in Personalized Medicine Market
  • 6.5.6.Rest of Europe Nanomaterials in Personalized Medicine Market
• 6.6.Asia-Pacific Nanomaterials in Personalized Medicine Market Snapshot
  • 6.6.1.China Nanomaterials in Personalized Medicine Market
  • 6.6.2.India Nanomaterials in Personalized Medicine Market
  • 6.6.3.Japan Nanomaterials in Personalized Medicine Market
  • 6.6.4.Australia Nanomaterials in Personalized Medicine Market
  • 6.6.5.South Korea Nanomaterials in Personalized Medicine Market
  • 6.6.6.Rest of Asia Pacific Nanomaterials in Personalized Medicine Market
• 6.7.Latin America Nanomaterials in Personalized Medicine Market Snapshot
  • 6.7.1.Brazil Nanomaterials in Personalized Medicine Market
  • 6.7.2.Mexico Nanomaterials in Personalized Medicine Market
• 6.8.Middle East & Africa Nanomaterials in Personalized Medicine Market
  • 6.8.1.Saudi Arabia Nanomaterials in Personalized Medicine Market
  • 6.8.2.South Africa Nanomaterials in Personalized Medicine Market
  • 6.8.3.Rest of Middle East & Africa Nanomaterials in Personalized Medicine Market

Chapter 7.Competitive Intelligence

• 7.1.Key Company SWOT Analysis
• 7.2.Top Market Strategies
• 7.3.Company Profiles
  • 7.3.1.Bristol-Myers Squibb Company
    • 7.3.1.1.Key Information
    • 7.3.1.2.Overview
    • 7.3.1.3.Financial (Subject to Data Availability)
    • 7.3.1.4.Product Summary
    • 7.3.1.5.Recent Developments
  • 7.3.2.Eisai Co., Ltd
  • 7.3.3.Gilead Sciences, Inc
  • 7.3.4.Ipsen Pharma S.A
  • 7.3.5.Abraxis BioScience, Inc
  • 7.3.6.Camurus AB
  • 7.3.7.Johnson & Johnson Services, Inc
  • 7.3.8.Merck & Co., Inc
  • 7.3.9.NanoCarrier Co., Ltd
  • 7.3.10.Novartis AG

Chapter 8.Research Process

• 8.1.Research Process
  • 8.1.1.Data Mining
  • 8.1.2.Analysis
  • 8.1.3.Market Estimation
  • 8.1.4.Validation
  • 8.1.5.Publishing
• 8.2.Research Attributes
• 8.3.Research Assumption